A biotechnology firm in Boston is seeking an Asset Lead for HMB-002 to drive the development of a novel therapy for von Willebrand disease. This pivotal role integrates strategy and execution, ensuring patient impact aligns with corporate objectives. The ideal candidate has over 12 years of relevant experience and a strong foundation in drug development, regulatory pathways, and cross-functional leadership.
#J-18808-Ljbffr